Bacteriophage therapy: a revitalized therapy against bacterial infectious diseases
References (109)
- et al.
Bacteriophages show promise as antimicrobial agents
J Infect
(1998) - et al.
Bacteriophage therapy and prophylaxis: rediscovery and renewed assessment of potential
Trends Microbiol
(1997) Phage therapy-advantages over antibiotics?
Lancet
(2000)Bacteriophage therapy offers new hope for streptococcal infections
Lancet
(2001)“My enemy's enemy is my friend.” Using phages to fight bacteria
Lancet
(2004)New dawn for phage therapy
Lancet Infect Dis
(2004)- et al.
Cloning and sequencing of major capsid protein (mcp) gene of a vibriophage, KVP20, possibly related to T-even coliphages
Gene (Amst)
(1998) - et al.
Evidence for the existence of a restriction-modification system common to several species of the family Vibrionaceae
FEMS Microbiol Lett
(1992) - et al.
Cloning and sequence analysis of Vibrio parahaemolyticus ompK gene encoding a 26-kDa outer membrane protein, OmpK, that serves as receptor for a broad-host-range vibriophage, KVP40
FEMS Microbiol Lett
(1995) - et al.
A vibriophage, KVP40, with major capsid protein homologous to gp23* of coliphage T4
Virology
(1998)
Helicobacter pylori-antigen-binding fragments expressed on the filamentous M13 phage prevent bacterial growth
Biochem Biophys Acta
(2000)
Complete nucleotide sequence and molecular characterization of the temperate staphylococcal bacteriophage ФPVL carrying Panton–Valentine leukocidin genes
Gene (Amst)
(1998)
Tailed bacteriophages: the order Caudovirales
Adv Virus Res
(1998)
Bacteriophage prevents destruction of skin grafts by Pseudomonas aeruginosa
Burns
(1994)
Treatment of post-burns bacterial infections by bacteriophages, specifically ubiquitous Pseudomonas spp. notoriously resistant to antibiotics
Med Hypotheses
(2002)
The emergence and evolution of methicillin-resistant Staphylococcus aureus
Trends Microbiol
(2001)
Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin
Lancet
(1997)
Trends in linezolid susceptibility patterns in 2002: report from the worldwide Zyvox Annual Appraisal of Potency and Spectrum Program
Diagn Microbiol Infect Dis
(2005)
Bacteriophage therapy of infectious diseases in aquaculture
Res Microbiol
(2002)
Optimizing concentration and timing of a phage spray application to reduce Listeria monocytogenes on honeydew melon tissue
J Food Prot
(2004)
Examination of bacteriophage as a biocontrol method for salmonella on fresh-cut fruit: a model study
J Food Prot
(2001)
Understanding bacteriophage therapy as a density-dependent kinetic process
J Theor Biol
(2001)
Models of phage growth and their applicability to phage therapy
J Theor Biol
(2004)
Multiple enzymatic activities of the murein hydrolase from staphylococcal phage S6154211
J Biol Chem
(1999)
Félix d’Herelle and the origins of molecular biology
(1999)
Bacteriophage therapy for bacterial infections. Rekindling a memory from the pre-antibiotics era
Perspect Biol Med
(2001)
Bacteriophage therapy
Antimicrob Agents Chemother
(2001)
Results of bacteriophage treatment of suppurative bacterial infections in the years 1981–1986
Arch Immunol Ther Exp
(1987)
Bacteriophage therapy of bacterial infections: an update of our institute's experience
Arch Immunol Ther Exp
(2000)
Phages and experience for their application in the former Soviet Union
(2002)
Phage therapy [editorial]
Lancet
(1983)
Smaller fleas ad infinitum: therapeutic bacteriophage redux
Proc Natl Acad Sci USA
(1996)
Phage therapy: past history and future prospects
Arch Immunol Ther Exp
(1999)
Bacteriophage therapy. Stalin's forgotten cure
Science
(2002)
The prospect for bacteriophage therapy in Western medicine
Nat Rev Drug Discov
(2003)
Set a microbe to kill a microbe: drug resistance renews interest in phage therapy
JAMA
(2003)
Population and evolutionary dynamics of phage therapy
Nat Rev Microbiol
(2004)
Renaissance phage [editorial]
Nat Rev Microbiol
(2004)
Viruses of prokaryotes. I. General properties of bacteriophages
(1987)
Frequency of morphological phage descriptions in the year 2000
Arch Virol
(2001)
A broad-host-range vibriophage, KVP40, isolated from sea water
Microbiol Immunol
(1992)
A 26-kDa outer membrane protein, OmpK, common to Vibrio species is the receptor for a broad-host-range vibriophage, KVP40
FEMS Microbiol Lett
(1995)
Major capsid proteins of certain Vibrio and Aeromonas phages are homologous to the equivalent protein, gp23*, of coliphage T4
Arch Virol
(1999)
Vibriophage KVP40 and coliphage T4 genomes share a homologous 7-kbp region immediately upstream of the gene encoding the major capsid protein
Arch Virol
(1999)
Sequence analysis of bacteriophage T4 DNA packaging/terminase genes 16 and 17 reveals a common ATPase center in the large subunit of viral terminases
Nucleic Acids Res
(2002)
Characterization of a novel Vibrio parahaemolyticus phage, KVP241, and its relatives frequently isolated from seawater
Microbiol Immunol
(2000)
Experimental protection of mice against lethal Staphylococcus aureus infection by novel bacteriophage S61542MR11
J Infect Dis
(2003)
Taxonomy of bacterial viruses: establishment of tailed virus genera and the order Caudovirales
Arch Virol
(1998)
Genetic evidence that the bacteriophage S61542X174 lysis protein inhibits cell wall synthesis
Proc Natl Acad Sci USA
(2000)
The lysis protein E of S61542X174 is a specific inhibitor of the MraY-catalyzed step in peptidoglycan synthesis
J Biol Chem
(2000)
Cited by (309)
Type I photodynamic antimicrobial therapy: Principles, progress, and future perspectives
2024, Acta BiomaterialiaSurface engineering of mesoporous bioactive glass nanoparticles with bacteriophages for enhanced antibacterial activity
2024, Colloids and Surfaces B: BiointerfacesNanomaterials-based photothermal therapies for antibacterial applications
2023, Materials and DesignUse of phages as antimicrobial agents
2023, Molecular Medical Microbiology, Third Edition
Copyright © 2005 Japanese Society of Chemotherapy and the Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.